Stocks and securities in focus
| Security | Change (%) | 1w | 1m ▼ | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ocular Therapeutix Inc. | -0.620% | 19.259% | 13.929% | 36.991% | 45.806% | -50.260% | 56.511% |
| Krystal Biotech | 0.800% | 4.655% | 12.363% | 53.273% | 45.345% | - | - |
| Karyopharm Therapeutics Inc. | 3.100% | 17.708% | 4.892% | -46.363% | 23.020% | -88.914% | - |
| Ceco Environmental Corp | -1.620% | 11.619% | 1.921% | 100.000% | 31.892% | 278.295% | 208.822% |
| Anavex Life Sciences Corp | -1.070% | 4.588% | -2.146% | -49.439% | -56.365% | -81.808% | 31.572% |
| Savara Inc. | 4.140% | 0.000% | -6.383% | 34.351% | -18.519% | 146.154% | 56.653% |
| Mersana Therapeutics | 4.680% | 3.344% | -9.763% | -29.734% | -6.256% | -83.237% | - |
| Microstrateg.a New | -2.650% | 2.048% | -10.055% | 361.933% | 130.814% | 202.580% | - |
| Pacific Biosciences of California Inc. | 0.060% | -15.026% | -24.682% | -88.660% | -86.099% | -95.402% | -75.166% |
| Verastem Inc. | 1.450% | -9.804% | -26.596% | 193.461% | -63.444% | -93.681% | - |
| G1 Therapeutics | 3.110% | -13.891% | -45.353% | -14.250% | -25.164% | -89.741% | - |
| Ebix Inc. | -20.810% | - | - | - | - | - | - |
| Voyager Therapeutics Inc | -1.440% | - | - | - | - | - | - |
| Avenue Therapeutics Inc. | 22.820% | - | - | - | - | - | - |
| Revance Therapeutics Inc. | 0.000% | - | - | - | - | - | - |